Neonatal screening for sickle cell disease in the Consorci Sanitari de Mataro. Justification and first results;Screening neonatal de drepanocitosis en el Consorci Sanitari de Mataro. Justificacion y primeros resultados

Anales Espanoles de Pediatria

Volumn 49, Issue 2, 1998, Pages 157-160

  Cabot Dalmau, A ^a,c   Casado Toda, M ^a   Barberan Perez J ^a   Roqueta Sureda, M ^a   Martorell Aymerich, Q ^a   Bosch Llobet, A ^b   Rovira Fernandez J M ^b  

^a Servicio de Pediatria

^b Servicio de Hematología

^c NONE   (Spain)

Author keywords

Hemoglobine electrophoresis; Neonatal screening; Sickle cell disease

Indexed keywords

HEMOGLOBIN;

ARTICLE; BETA THALASSEMIA; EARLY DIAGNOSIS; ELECTROPHORESIS; ETHNIC GROUP; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN SCREENING; PREVALENCE; SICKLE CELL ANEMIA;

ANEMIA, SICKLE CELL; FEMALE; HUMANS; INFANT, NEWBORN; MALE; NEONATAL SCREENING; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; SPAIN;

EID: 0001419351     PISSN: 03024342     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Balanzó X, Fernández-Roura JLI, Cabot A. Desenvolupament d'una unitat d'atenció sanitària per a minories ètniques en un Hospital general bàsic. VI Reunió anual Societat de Salut Pública de Catalunya i Balears. 16-17 octubre 1992, Barcelona.
2. Cabot, A. Problemes de salut en fills d'immigrants africans. Població negra d'origen centre-africà. Pediatr Catalana 1996; 56:6-10.
3. Horn MEC, Dick MC, Frost B, Davis LR, Bellingham AJ, Stroud CE, Studd JW. Neonatal screening for sickle cell diseases in Camberwell: results and recommendations of a two year pilot study. BMJ 1986; 292:737-740.
4. Lee A, Thomas P, Cupidore L, Serjeant B, Serjeant G. Improved survival in homozygous sickle cell disease: lessons from a cohort study. BMJ 1995; 311:1600-1602.
5. Gray A, Anionwu EN, Davies SC, Brozovic M. Patterns of mortality in sickle cell disease in the United Kingdom. J Clin Pathol 1991; 44:459-463.
6. Samuels-Reid JH. Common problems in sickle cell disease. Am Fam Physician 1994; 49:1483-1486.
7. Wang W, Day S, Turner E, Bhakta M, Erickson S. Medical management and prevention guidelines for children with sickle cell disease. J Tenn Med Assoc 1992; 85:209-214.
8. Lane P, Eckman J. Cost-effectiveness of neonatal screening for sickle cell disease (letter). J Pediatr 1992; 120:162-163.
9. Sprinkle RH, Hynes DM, Konrad TR. Is universal neonatal hemoglobinopathy screening cost-effective? Arch Pediatr Adolesc Med 1994; 148:461-469.
10. Githens JH, Lane PA, McCurdy RS, Houston ML, McKinna JD, Cole BM. Newborn screeening for hemoglobinopathies in Colorado. The first 10 years. Am J Dis Child 1990; 144:466-470.
11. Selekman J. Update: new guidelines for the treatment of infants with sickle cell disease. Agency for Health Care Policy and Reasearch. Pediatr Nurs 1993; 19:600-605.
12. Irons M. Evaluación en busca de transtornos metabólicos: situación actual. Pediatr Clin North Am 1993; 40:1073-1085.
13. Tsevat J, Wong JB, Pauker SG, Steinberg MH. Neonatal screening for sickle cell disease: a cost-effectiveness analysis. J Pediatr 1991; 118:546-554.
14. Le Gales C, Galacteros F. [Economic analysis of neonatal screening for drepanocytosis in metropolitan France]. Rev Epidemiol Santé Publique 1994; 42:478-492.
15. Bergman AB. Is universal neonatal hemoglobinopathy screening cost-effective? (letter). Arch Pediatr Adolesc Med 1995; 149:466
16. Roa D, Turner EA, Aguinaga MP. Reference ranges for hemoglobin variants by HPLC in african americans. Ann Clin Lab Sci 1995; 25:228-235.
17. Pic P, Ducrocq R, Girot R. Séparation des hémoglobines F, Fac, S, C, A1c et dosage de l'hemoglobine F par chromatographic liquide haute performance. Ann Biol Clin 1994; 52:129-132.
18. Eastman JW, Wong R, Liao CL, Morales D. Automated HPLC screening of newborns for sickle cell anemia and other hemoglobinopathies. Clin Chem 1996; 42:704-710.